Correlation Between Maximal Tongue Pressure and Swallowing Function in Spinal and Bulbar Muscular Atrophy

被引:5
|
作者
Gwak, Dae-Won [1 ]
Jung, Seung-Hwan [1 ]
Min, Yu-Sun [1 ]
Park, Jin-Sung [2 ]
Cho, Hee-Jin [2 ]
Park, Donghwi [3 ]
Hong, Min Woo [4 ]
Kang, Min-Gu [4 ]
机构
[1] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Rehabil Med, Daegu, South Korea
[2] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea
[3] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Phys Med & Rehabil, Ulsan, South Korea
[4] Dong A Univ, Dong A Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Busan, South Korea
来源
FRONTIERS IN NEUROLOGY | 2021年 / 12卷
关键词
bulbo-spinal atrophy X-linked; motor neuron disease; neurodegenerative diseases; tongue; deglutition disorders; RECESSIVE BULBOSPINAL NEURONOPATHY; KENNEDY-DISEASE; DYSPHAGIA; DIAGNOSIS;
D O I
10.3389/fneur.2021.704788
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Spinal and bulbar muscular atrophy (SBMA) is an X-lined motor neuron disease characterized by progressive muscle weakness, bulbar palsy, and dysphagia. Dysphagia is associated with tongue weakness, which is a common manifestation of SBMA. This study aimed to investigate the correlations between tongue pressure and dysphagia in patients with SBMA. Materials and Methods: Thirty-nine genetically confirmed SBMA patients underwent a videofluoroscopic swallowing study (VFSS) and tongue pressure assessment. Then, we analyzed the maximal tongue pressure (MTP), oral transit time, penetration-aspiration scale (PAS), videofluoroscopic dysphagia scale (VDS), amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R), and 6-min walk test (6MWT). Pearson and Spearman correlation coefficients were calculated to analyze the association of the MTP with clinical, swallowing, and functional parameters. Results: In the correlation analysis, MTP was negatively correlated with disease duration (r = -0.396, p = 0.013) and VDS (r = -0.426, p = 0.007), and positively correlated with ALSFRS-R (r = 0.483, p = 0.002) and 6MWT (r = 0.396, p = 0.013). The bulbar (r = 0.367, p = 0.022) and gross motor (r = 0.486, p = 0.002) domains of the ALSFRS-R were correlated with MTP. Conclusion: Tongue pressure assessment can be used as a safe and easy tool to assess swallowing function in SBMA patients. Moreover, MTP reflects functional states, including activities of daily living and gait performance, showing it to be a potential biomarker for physical performance in SBMA.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes
    Young, Sally Dunaway
    Pasternak, Amy
    Duong, Tina
    McGrattan, Katlyn E.
    Stranberg, Sarah
    Maczek, Elizabeth
    Dias, Courtney
    Tang, Whitney
    Parker, Dana
    Levine, Alexis
    Rohan, Alyssa
    Wolford, Connie
    Martens, William
    McDermott, Michael P.
    Darras, Basil T.
    Day, John W.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (02) : 199 - 209
  • [32] X-linked spinal and bulbar muscular atrophy without proximal atrophy
    Boz, C
    Sahin, N
    Kalay, E
    Velioglu, S
    Ozmenoglu, M
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 105 (01) : 14 - 17
  • [33] Trajectory of change in the swallowing status in spinal muscular atrophy type I
    Choi, Young-Ah
    Suh, Dong In
    Chae, Jong-Hee
    Shin, Hyung-Ik
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2020, 130
  • [34] Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia
    A Lund
    B Udd
    V Juvonen
    P M Andersen
    K Cederquist
    L-O Ronnevi
    P Sistonen
    SA Sörensen
    L Tranebjærg
    C Wallgren-Pettersson
    M-L Savontaus
    European Journal of Human Genetics, 2000, 8 : 631 - 636
  • [35] Patients with Spinal Muscular Atrophy Type 1 Achieve and Maintain Bulbar Function Following Onasemnogene Abeparvovec Treatment
    McGrattan, Katlyn E.
    Shell, Richard D.
    Hurst-Davis, Rebecca
    Young, Sally Dunaway
    O'Brien, Eamonn
    Lavrov, Arseniy
    Wallach, Shiri
    LaMarca, Nicole
    Reyna, Sandra P.
    Darras, Basil T.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (04) : 531 - 540
  • [36] Progress toward the development of treatment of spinal and bulbar muscular atrophy
    Sahashi, Kentaro
    Hashizume, Atsushi
    Sobue, Gen
    Katsuno, Masahisa
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 503 - 514
  • [37] Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy
    Hashizume, Atsushi
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Suga, Noriaki
    Mano, Tomoo
    Atsuta, Naoki
    Oe, Hiroaki
    Watanabe, Hirohisa
    Tanaka, Fumiaki
    Sobue, Gen
    BRAIN, 2012, 135 : 2838 - 2848
  • [38] Bulbar and spinal muscular atrophy (Kennedy's disease): a review
    Finsterer, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (05) : 556 - 561
  • [39] Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia
    Lund, A
    Udd, B
    Juvonen, V
    Andersen, PM
    Cederquist, K
    Ronnevi, LO
    Sistonen, P
    Sörensen, SA
    Tranebjærg, L
    Wallgren-Pettersson, C
    Savontaus, ML
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (08) : 631 - 636
  • [40] Autosomal dominant familial spinal and bulbar muscular atrophy with gynecomastia
    Ikezoe, K
    Yoshimura, T
    Taniwaki, T
    Matsuura, E
    Furuya, H
    Yamada, T
    Nagamatsu, K
    Kira, J
    NEUROLOGY, 1999, 53 (09) : 2187 - 2189